Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

Pharmacodynamics in Geriatric Patients: Effects of Age

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

Pharmacodynamics: Overview and Principles

Pharmacodynamics: Overview and Principles

Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...

Drug Administration and Therapy Phases: Overview

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evaluation of adalimumab tapering regimens in children and adolescents with juvenile idiopathic arthritis in remission: a simulation study.

Pediatric rheumatology online journal·2026

Same author

Evaluating Tranexamic Acid Dosing Strategies for Postpartum Hemorrhage: A Population Pharmacokinetic Approach in Pregnant Individuals.

Journal of clinical pharmacology·2025

Same author

Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases.

Pediatric rheumatology online journal·2024

Same author

Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years.

Paediatric drugs·2022

Same author

Plasma concentration guided dosing of drugs used for the treatment of childhood leukaemias: protocol for a systematic review.

BMJ open·2022

Same author

A simplified method for bortezomib determination using dried blood spots in combination with liquid chromatography/tandem mass spectrometry.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2021

Search research articles

Related Experiment Video

Updated: Jun 7, 2026

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans

Published on: February 4, 2014

Developmental pharmacology.

Johannes N van den Anker¹

¹Division of Pediatric Clinical Pharmacology, George Washington University Medical Center, Children's National Medical Center, Washington DC, USA. jvandena@cnmc.org

Developmental Disabilities Research Reviews

|October 29, 2010

Summary

Pediatric psychopharmacology faces challenges in drug dosing due to developmental changes. This review highlights key pharmacokinetic and pharmacodynamic differences in children, focusing on enzyme variations like CYP2D6 for safer medication use.

More Related Videos

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells (NPCs)

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells (NPCs)

Published on: March 2, 2018

Related Experiment Videos

Last Updated: Jun 7, 2026

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans

Published on: February 4, 2014

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells (NPCs)

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells (NPCs)

Published on: March 2, 2018

Area of Science:

Pharmacology
Developmental Biology
Pediatrics

Background:

Pediatric psychopharmacology presents unique challenges in drug administration.
Current dosing strategies often lack a strong scientific rationale.
Understanding developmental changes in drug handling is crucial for effective treatment.

Purpose of the Study:

To review developmental changes in drug absorption, distribution, metabolism, and elimination (ADME) in pediatric populations.
To emphasize the role of metabolic pathways and enzyme development in psychotropic drug biotransformation.
To discuss the impact of genetic variations, particularly in CYP2D6, on drug metabolism.

Main Methods:

Comprehensive literature review of existing data on pediatric pharmacokinetics and pharmacodynamics.
Focus on developmental changes in drug metabolism, including specific enzyme systems.
Analysis of genetic polymorphisms affecting drug-metabolizing enzymes.

Main Results:

Significant developmental variations exist in pediatric drug ADME profiles.
Immature metabolic pathways and developing enzymes impact drug efficacy and safety.
Genetic variations in CYP2D6 substantially influence psychotropic drug metabolism in children.

Conclusions:

Rational drug use in pediatric psychopharmacology requires understanding developmental pharmacokinetics.
Developmental pharmacologists play a key role in translating research into clinical practice.
Tailoring drug therapy based on developmental and genetic factors is essential for optimal outcomes.